1-3 of 3
Benjamin Ribba
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 690: Optimization of biopsy scheduling in clinical studies of T cell bispecifics through an integrated modeling and simulation, digital pathology and machine learning approach

Lucy G. Hutchinson, Antoine Soubret, Benjamin Ribba, Jean-Eric Charoin, Alex Phipps, Richard Peck, Oliver Grimm
Journal: Cancer Research
Cancer Res (2019) 79 (13_Supplement): 690.
https://doi.org/10.1158/1538-7445.AM2019-690
Published: 01 July 2019
View article titled, Abstract 690: Optimization of biopsy scheduling in clinical studies of T cell bispecifics through an integrated modeling and simulation, digital pathology and machine learning approach
Journal Articles

Early Prediction of Disease Progression in Small Cell Lung Cancer: Toward Model-Based Personalized Medicine in Oncology

Núria Buil-Bruna, Tarjinder Sahota, José-María López-Picazo, Marta Moreno-Jiménez, Salvador Martín-Algarra, Benjamin Ribba, Iñaki F. Trocóniz
Journal: Cancer Research
Cancer Res (2015) 75 (12): 2416–2425.
https://doi.org/10.1158/0008-5472.CAN-14-2584
Published: 14 June 2015
View article titled, Early Prediction of Disease Progression in Small Cell Lung Cancer: Toward Model-Based Personalized Medicine in Oncology
Open the PDF for Early Prediction of Disease Progression in Small Cell Lung Cancer: Toward Model-Based Personalized Medicine in Oncology in another window
Includes: Supplementary data
Journal Articles

A new concept: “PSA clearance” predicts biochemical relapse risk of patients with prostate cancer in the first month following radical prostatectomy.

Benoit You, Paul Perrin, Gilles Freyer, Claire Falandry, Benjamin Ribba, Emilie Henin, Alain Ruffion, Philippe Paparel, Brigitte Tranchand, Olivier Tredan, Jean-Pierre Droz, Pascal Girard
Journal: Cancer Research
Cancer Res (2008) 68 (9_Supplement): 969.
Published: 01 May 2008
View article titled, A new concept: “PSA clearance” predicts biochemical relapse risk of patients with prostate cancer in the first month following radical prostatectomy.